Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/22/2014 07/23/2014 07/24/2014 07/25/2014 07/28/2014 Date
49.12(c) 49.32(c) 49.46(c) 49.39(c) 49.8 Last
5 015 923 6 281 228 8 752 157 5 872 244 6 378 347 Volume
+0.41% +0.41% +0.28% -0.14% +0.83% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
10/22Earnings Release
Surperformance© rating of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More about the company
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15 583 M
EBIT 2014 3 302 M
Net income 2014 2 819 M
Finance 2014 234 M
Yield 2014 2,92%
Sales 2015 15 336 M
EBIT 2015 3 025 M
Net income 2015 2 564 M
Finance 2015 535 M
Yield 2015 2,99%
PER 2014 29,55
PER 2015 28,93
EV / Sales 2014 5,24x
EV / Sales 2015 5,30x
Capitalization 81 884 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
14h ago Pfizer's need for deal looms larger with earnings report
3d ago AstraZeneca results to get lift from bid foe Pfizer
3d ago BRISTOL MYERS SQUIBB : Biocon Reports Revenue Of INR7.4 Billion In Q1 Fiscal 201..
3d ago BRISTOL MYERS SQUIBB : Assigned Patent
4d ago BRISTOL MYERS SQUIBB : BioMed Realty And Bristol-Myers Squibb Sign Lease To Expa..
4d ago BRISTOL MYERS SQUIBB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
4d agoDJBRISTOL MYERS SQUIBB : -Myers Posts Lower Profit, Revenue -- Update
4d ago BRISTOL MYERS SQUIBB : Results of Operations and Financial Condition, Financial ..
4d ago BRISTOL MYERS SQUIBB : Reports Second Quarter 2014 Financial Results
5d ago BRISTOL MYERS SQUIBB : Patent Application Titled "Enediyne Compounds, Conjugates..
5d ago BRISTOL MYERS SQUIBB : Trademark Application for "VIGLEEF" Filed by Bristol-Myer..
5d ago BRISTOL MYERS SQUIBB : Trademark Application for "XUNVEK" Filed by Bristol-Myers..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
Bristol-Myers Squibb Co : Income Statement Evolution
More Financials
EPS Revisions
Bristol-Myers Squibb Co : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF